Головна сторінка Огляд Довідка
Реєстрація Увійти
liaoxg
/
cfc
1
1
Відгалуження 0
Файли Проблеми 0 Запити на злиття 0 Wiki
Дерево: 4e925e144d
Гілки Теги
cfc
/
web
/
articles
/
alzheimer.html

alzheimer.html 53 KB
Історія Запис

1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677787980818283848586878889909192939495969798991001011021031041051061071081091101111121131141151161171181191201211221231241251261271281291301311321331341351361371381391401411421431441451461471481491501511521531541551561571581591601611621631641651661671681691701711721731741751761771781791801811821831841851861871881891901911921931941951961971981992002012022032042052062072082092102112122132142152162172182192202212222232242252262272282292302312322332342352362372382392402412422432442452462472482492502512522532542552562572582592602612622632642652662672682692702712722732742752762772782792802812822832842852862872882892902912922932942952962972982993003013023033043053063073083093103113123133143153163173183193203213223233243253263273283293303313323333343353363373383393403413423433443453463473483493503513523533543553563573583593603613623633643653663673683693703713723733743753763773783793803813823833843853863873883893903913923933943953963973983994004014024034044054064074084094104114124134144154164174184194204214224234244254264274284294304314324334344354364374384394404414424434444454464474484494504514524534544554564574584594604614624634644654664674684694704714724734744754764774784794804814824834844854864874884894904914924934944954964974984995005015025035045055065075085095105115125135145155165175185195205215225235245255265275285295305315325335345355365375385395405415425435445455465475485495505515525535545555565575585595605615625635645655665675685695705715725735745755765775785795805815825835845855865875885895905915925935945955965975985996006016026036046056066076086096106116126136146156166176186196206216226236246256266276286296306316326336346356366376386396406416426436446456466476486496506516526536546556566576586596606616626636646656666676686696706716726736746756766776786796806816826836846856866876886896906916926936946956966976986997007017027037047057067077087097107117127137147157167177187197207217227237247257267277287297307317327337347357367377387397407417427437447457467477487497507517527537547557567577587597607617627637647657667677687697707717727737747757767777787797807817827837847857867877887897907917927937947957967977987998008018028038048058068078088098108118128138148158168178188198208218228238248258268278288298308318328338348358368378388398408418428438448458468478488498508518528538548558568578588598608618628638648658668678688698708718728738748758768778788798808818828838848858868878888898908918928938948958968978988999009019029039049059069079089099109119129139149159169179189199209219229239249259269279289299309319329339349359369379389399409419429439449459469479489499509519529539549559569579589599609619629639649659669679689699709719729739749759769779789799809819829839849859869879889899909919929939949959969979989991000100110021003100410051006100710081009101010111012101310141015101610171018101910201021102210231024102510261027102810291030103110321033103410351036103710381039104010411042104310441045104610471048104910501051105210531054105510561057105810591060106110621063106410651066106710681069107010711072107310741075107610771078107910801081108210831084108510861087108810891090109110921093109410951096109710981099110011011102110311041105110611071108110911101111111211131114111511161117111811191120112111221123112411251126112711281129113011311132113311341135113611371138113911401141114211431144114511461147114811491150115111521153115411551156115711581159116011611162116311641165116611671168116911701171117211731174117511761177117811791180118111821183118411851186118711881189119011911192119311941195119611971198119912001201120212031204120512061207120812091210121112121213121412151216121712181219122012211222122312241225122612271228122912301231123212331234123512361237123812391240124112421243124412451246124712481249125012511252125312541255125612571258125912601261126212631264126512661267126812691270127112721273127412751276127712781279128012811282128312841285128612871288128912901291129212931294129512961297129812991300130113021303130413051306130713081309131013111312131313141315131613171318131913201321132213231324132513261327132813291330133113321333133413351336 
  1. <!DOCTYPE html>
    2. 

  2. <html lang="zh-CN">
    3. 

  3. <head>
    4. 

  4. <meta charset="UTF-8">
    5. 

  5. <meta name="viewport" content="width=device-width, initial-scale=1.0">
    6. 

  6. <meta name="description" content="老年痴呆 - 神经炎症、肠脑轴与主动健康：Aβ斑块在症状出现前15年就开始沉积。老年痴呆的本质是大脑的慢性神经炎症——肠脑轴失调是小胶质细胞失控的根源。">
    7. 

  7. <meta name="keywords" content="阿尔茨海默病,神经炎症,肠脑轴,小胶质细胞,Aβ淀粉样斑块,tau蛋白缠结,神经退行性疾病,主动健康,预防医学">
    8. 

  8. <meta property="og:title" content="老年痴呆 - 神经炎症、肠脑轴与主动健康 · 浠艾福">
    9. 

  9. <meta property="og:description" content="Aβ斑块在症状出现前15年就开始沉积。老年痴呆的本质是大脑的慢性神经炎症——肠脑轴失调是小胶质细胞失控的根源。">
    10. 

  10. <meta property="og:type" content="article">
    11. 

  11. <title>老年痴呆 - 神经炎症、肠脑轴与主动健康 · 浠艾福</title>
    12. 

  12. <style>
    13. 

  13.   :root {
    14. 

  14.     --bg-dark: #1a1a3a;
    15. 

  15.     --bg-card: #FFFFFF;
    16. 

  16.     --bg-alt: #f0f7f0;
    17. 

  17.     --text-primary: #1a1a3a;
    18. 

  18.     --text-secondary: #4a5568;
    19. 

  19.     --text-muted: #718096;
    20. 

  20.     --accent: #27ae60;
    21. 

  21.     --accent-light: #eafaf1;
    22. 

  22.     --blue: #2d7d9a;
    23. 

  23.     --blue-light: #e8f4f8;
    24. 

  24.     --green: #38a169;
    25. 

  25.     --green-light: #f0fff4;
    26. 

  26.     --orange: #dd6b20;
    27. 

  27.     --orange-light: #fffaf0;
    28. 

  28.     --purple: #805ad5;
    29. 

  29.     --purple-light: #faf5ff;
    30. 

  30.     --teal: #319795;
    31. 

  31.     --teal-light: #e6fffa;
    32. 

  32.     --font: system-ui, -apple-system, "PingFang SC", "Microsoft YaHei", "Noto Sans SC", sans-serif;
    33. 

  33.     --max-width: 1080px;
    34. 

  34.     --shadow-card: 0 4px 24px rgba(0,0,0,0.08);
    35. 

  35.     --shadow-hover: 0 8px 40px rgba(0,0,0,0.12);
    36. 

  36.     --radius: 16px;
    37. 

  37.   }
    38. 

  38.   * { margin: 0; padding: 0; box-sizing: border-box; }
    39. 

  39.   html { scroll-behavior: smooth; }
    40. 

  40.   body {
    41. 

  41.     font-family: var(--font);
    42. 

  42.     font-size: 1rem;
    43. 

  43.     line-height: 1.8;
    44. 

  44.     color: var(--text-primary);
    45. 

  45.     background: #fff;
    46. 

  46.     -webkit-font-smoothing: antialiased;
    47. 

  47.   }
    48. 

  48. 

  49.   /* HERO */
    50. 

  50.   .hero {
    51. 

  51.     position: relative;
    52. 

  52.     background: linear-gradient(135deg, #1a1a3a 0%, #2d2d6b 40%, #3a3a8c 100%);
    53. 

  53.     color: white;
    54. 

  54.     padding: 6rem 1.5rem 4rem;
    55. 

  55.     overflow: hidden;
    56. 

  56.     min-height: 60vh;
    57. 

  57.     display: flex;
    58. 

  58.     align-items: center;
    59. 

  59.   }
    60. 

  60.   .hero::before {
    61. 

  61.     content: '';
    62. 

  62.     position: absolute;
    63. 

  63.     inset: 0;
    64. 

  64.     background:
    65. 

  65.       radial-gradient(circle at 20% 30%, rgba(139,92,246,0.15) 0%, transparent 50%),
    66. 

  66.       radial-gradient(circle at 80% 70%, rgba(99,102,241,0.1) 0%, transparent 50%);
    67. 

  67.   }
    68. 

  68.   .hero-particles {
    69. 

  69.     position: absolute;
    70. 

  70.     inset: 0;
    71. 

  71.     overflow: hidden;
    72. 

  72.     pointer-events: none;
    73. 

  73.   }
    74. 

  74.   .particle {
    75. 

  75.     position: absolute;
    76. 

  76.     width: 6px; height: 6px;
    77. 

  77.     background: rgba(255,255,255,0.12);
    78. 

  78.     border-radius: 50%;
    79. 

  79.     animation: float 8s ease-in-out infinite;
    80. 

  80.   }
    81. 

  81.   .particle:nth-child(1) { left: 10%; top: 20%; animation-delay: 0s; width: 4px; height: 4px; }
    82. 

  82.   .particle:nth-child(2) { left: 25%; top: 60%; animation-delay: 1s; width: 8px; height: 8px; opacity: 0.1; }
    83. 

  83.   .particle:nth-child(3) { left: 45%; top: 15%; animation-delay: 2s; width: 5px; height: 5px; }
    84. 

  84.   .particle:nth-child(4) { left: 65%; top: 70%; animation-delay: 0.5s; width: 3px; height: 3px; }
    85. 

  85.   .particle:nth-child(5) { left: 80%; top: 30%; animation-delay: 3s; width: 7px; height: 7px; opacity: 0.08; }
    86. 

  86.   .particle:nth-child(6) { left: 15%; top: 85%; animation-delay: 1.5s; width: 4px; height: 4px; }
    87. 

  87.   .particle:nth-child(7) { left: 55%; top: 45%; animation-delay: 2.5s; width: 9px; height: 9px; opacity: 0.12; }
    88. 

  88.   @keyframes float {
    89. 

  89.     0%, 100% { transform: translateY(0) scale(1); opacity: 0.12; }
    90. 

  90.     50% { transform: translateY(-30px) scale(1.5); opacity: 0.25; }
    91. 

  91.   }
    92. 

  92.   .hero-content {
    93. 

  93.     position: relative;
    94. 

  94.     z-index: 1;
    95. 

  95.     max-width: var(--max-width);
    96. 

  96.     margin: 0 auto;
    97. 

  97.     text-align: center;
    98. 

  98.     width: 100%;
    99. 

  99.   }
    100. 

  100.   .hero-badge {
    101. 

  101.     display: inline-block;
    102. 

  102.     background: rgba(139,92,246,0.2);
    103. 

  103.     color: #a78bfa;
    104. 

  104.     font-size: 0.75rem;
    105. 

  105.     font-weight: 600;
    106. 

  106.     letter-spacing: 0.08em;
    107. 

  107.     padding: 0.35rem 1rem;
    108. 

  108.     border-radius: 999px;
    109. 

  109.     border: 1px solid rgba(139,92,246,0.3);
    110. 

  110.     margin-bottom: 1.5rem;
    111. 

  111.   }
    112. 

  112.   .hero h1 {
    113. 

  113.     font-size: clamp(2rem, 5vw, 3.2rem);
    114. 

  114.     font-weight: 800;
    115. 

  115.     line-height: 1.2;
    116. 

  116.     margin-bottom: 1rem;
    117. 

  117.     background: linear-gradient(135deg, #fff 40%, #c4b5fd 100%);
    118. 

  118.     -webkit-background-clip: text;
    119. 

  119.     -webkit-text-fill-color: transparent;
    120. 

  120.     background-clip: text;
    121. 

  121.   }
    122. 

  122.   .hero p {
    123. 

  123.     font-size: clamp(1rem, 2vw, 1.2rem);
    124. 

  124.     color: rgba(255,255,255,0.8);
    125. 

  125.     max-width: 700px;
    126. 

  126.     margin: 0 auto 2rem;
    127. 

  127.     line-height: 1.7;
    128. 

  128.   }
    129. 

  129.   .hero-stats {
    130. 

  130.     display: flex;
    131. 

  131.     gap: 1.5rem;
    132. 

  132.     justify-content: center;
    133. 

  133.     flex-wrap: wrap;
    134. 

  134.     margin-top: 2rem;
    135. 

  135.   }
    136. 

  136.   .hero-stat {
    137. 

  137.     background: rgba(255,255,255,0.08);
    138. 

  138.     backdrop-filter: blur(8px);
    139. 

  139.     border: 1px solid rgba(255,255,255,0.1);
    140. 

  140.     border-radius: 12px;
    141. 

  141.     padding: 1rem 1.5rem;
    142. 

  142.     text-align: center;
    143. 

  143.     min-width: 130px;
    144. 

  144.   }
    145. 

  145.   .hero-stat .num {
    146. 

  146.     font-size: 1.75rem;
    147. 

  147.     font-weight: 800;
    148. 

  148.     color: #a78bfa;
    149. 

  149.     display: block;
    150. 

  150.   }
    151. 

  151.   .hero-stat .label {
    152. 

  152.     font-size: 0.8rem;
    153. 

  153.     color: rgba(255,255,255,0.6);
    154. 

  154.     margin-top: 0.2rem;
    155. 

  155.   }
    156. 

  156. 

  157.   /* TOC */
    158. 

  158.   .toc {
    159. 

  159.     background: white;
    160. 

  160.     border-bottom: 1px solid #e2e8f0;
    161. 

  161.     position: sticky;
    162. 

  162.     top: 0;
    163. 

  163.     z-index: 100;
    164. 

  164.     box-shadow: 0 1px 4px rgba(0,0,0,0.04);
    165. 

  165.   }
    166. 

  166.   .toc-inner {
    167. 

  167.     max-width: var(--max-width);
    168. 

  168.     margin: 0 auto;
    169. 

  169.     padding: 0.75rem 1.5rem;
    170. 

  170.     display: flex;
    171. 

  171.     gap: 0.25rem;
    172. 

  172.     overflow-x: auto;
    173. 

  173.     -webkit-overflow-scrolling: touch;
    174. 

  174.   }
    175. 

  175.   .toc-inner a {
    176. 

  176.     flex-shrink: 0;
    177. 

  177.     text-decoration: none;
    178. 

  178.     font-size: 0.85rem;
    179. 

  179.     color: var(--text-muted);
    180. 

  180.     padding: 0.4rem 0.8rem;
    181. 

  181.     border-radius: 6px;
    182. 

  182.     transition: all 0.2s;
    183. 

  183.     white-space: nowrap;
    184. 

  184.   }
    185. 

  185.   .toc-inner a:hover { background: var(--bg-alt); color: var(--text-primary); }
    186. 

  186. 

  187.   .container { max-width: var(--max-width); margin: 0 auto; padding: 0 1.5rem; }
    188. 

  188.   section { padding: 4rem 0; }
    189. 

  189.   section.alt { background: var(--bg-alt); }
    190. 

  190. 

  191.   h2 {
    192. 

  192.     font-size: 1.75rem;
    193. 

  193.     font-weight: 700;
    194. 

  194.     margin-bottom: 1.5rem;
    195. 

  195.     line-height: 1.3;
    196. 

  196.   }
    197. 

  197.   h2 .emoji { margin-right: 0.5rem; }
    198. 

  198.   h3 {
    199. 

  199.     font-size: 1.15rem;
    200. 

  200.     font-weight: 600;
    201. 

  201.     margin: 2rem 0 0.75rem;
    202. 

  202.   }
    203. 

  203.   h3:first-child { margin-top: 0; }
    204. 

  204.   p { margin-bottom: 1rem; color: var(--text-secondary); }
    205. 

  205.   .alt p { color: var(--text-secondary); }
    206. 

  206. 

  207.   /* Highlight Box */
    208. 

  208.   .highlight-box {
    209. 

  209.     border-radius: var(--radius);
    210. 

  210.     padding: 1.5rem 2rem;
    211. 

  211.     margin: 1.5rem 0;
    212. 

  212.     border-left: 4px solid;
    213. 

  213.   }
    214. 

  214.   .highlight-box.green { background: var(--green-light); border-color: var(--green); }
    215. 

  215.   .highlight-box.blue { background: var(--blue-light); border-color: var(--blue); }
    216. 

  216.   .highlight-box.orange { background: var(--orange-light); border-color: var(--orange); }
    217. 

  217.   .highlight-box.purple { background: var(--purple-light); border-color: var(--purple); }
    218. 

  218.   .highlight-box.teal { background: var(--teal-light); border-color: var(--teal); }
    219. 

  219.   .highlight-box p:last-child { margin-bottom: 0; }
    220. 

  220. 

  221.   /* Citation Card */
    222. 

  222.   .citation-card {
    223. 

  223.     background: white;
    224. 

  224.     border: 1px solid #e2e8f0;
    225. 

  225.     border-radius: var(--radius);
    226. 

  226.     padding: 1.25rem 1.5rem;
    227. 

  227.     box-shadow: var(--shadow-card);
    228. 

  228.     transition: box-shadow 0.2s;
    229. 

  229.     margin-bottom: 1rem;
    230. 

  230.   }
    231. 

  231.   .citation-card:hover { box-shadow: var(--shadow-hover); }
    232. 

  232.   .citation-card .source {
    233. 

  233.     font-size: 0.75rem;
    234. 

  234.     color: var(--blue);
    235. 

  235.     font-weight: 600;
    236. 

  236.     text-transform: uppercase;
    237. 

  237.     letter-spacing: 0.05em;
    238. 

  238.   }
    239. 

  239.   .citation-card .title { font-weight: 600; font-size: 0.95rem; margin: 0.3rem 0 0.4rem; line-height: 1.4; }
    240. 

  240.   .citation-card .findings { font-size: 0.85rem; color: var(--text-muted); line-height: 1.6; }
    241. 

  241.   .citation-card .link {
    242. 

  242.     display: inline-block; margin-top: 0.5rem; font-size: 0.8rem;
    243. 

  243.     color: var(--blue); text-decoration: none;
    244. 

  244.   }
    245. 

  245.   .citation-card .link:hover { text-decoration: underline; }
    246. 

  246. 

  247.   /* Data Card */
    248. 

  248.   .data-card {
    249. 

  249.     background: white;
    250. 

  250.     border-radius: var(--radius);
    251. 

  251.     padding: 2rem;
    252. 

  252.     text-align: center;
    253. 

  253.     box-shadow: var(--shadow-card);
    254. 

  254.   }
    255. 

  255.   .data-card .big-number {
    256. 

  256.     font-size: 3rem; font-weight: 800; line-height: 1;
    257. 

  257.   }
    258. 

  258.   .data-card .big-number.green { color: var(--green); }
    259. 

  259.   .data-card .big-number.blue { color: var(--blue); }
    260. 

  260.   .data-card .big-number.orange { color: var(--orange); }
    261. 

  261.   .data-card .unit { font-size: 1rem; color: var(--text-muted); font-weight: 400; }
    262. 

  262.   .data-card .desc { font-size: 0.9rem; color: var(--text-secondary); margin-top: 0.5rem; }
    263. 

  263.   .data-grid {
    264. 

  264.     display: grid;
    265. 

  265.     grid-template-columns: repeat(auto-fit, minmax(220px, 1fr));
    266. 

  266.     gap: 1.5rem;
    267. 

  267.     margin: 1.5rem 0;
    268. 

  268.   }
    269. 

  269. 

  270.   /* Two Col Grid */
    271. 

  271.   .two-col-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; }
    272. 

  272.   .two-col-grid-3 { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1rem; }
    273. 

  273. 

  274.   /* Tip Card */
    275. 

  275.   .tip-card {
    276. 

  276.     background: white;
    277. 

  277.     border-radius: var(--radius);
    278. 

  278.     padding: 1.5rem;
    279. 

  279.     box-shadow: var(--shadow-card);
    280. 

  280.     border-top: 3px solid;
    281. 

  281.   }
    282. 

  282.   .tip-card.green { border-color: var(--green); }
    283. 

  283.   .tip-card.blue { border-color: var(--blue); }
    284. 

  284.   .tip-card.orange { border-color: var(--orange); }
    285. 

  285.   .tip-card.purple { border-color: var(--purple); }
    286. 

  286.   .tip-card .tip-icon { font-size: 1.75rem; margin-bottom: 0.5rem; }
    287. 

  287.   .tip-card h4 { font-size: 1rem; font-weight: 600; margin-bottom: 0.4rem; }
    288. 

  288.   .tip-card p { font-size: 0.85rem; color: var(--text-muted); margin-bottom: 0; }
    289. 

  289.   .tip-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 1rem; }
    290. 

  290. 

  291.   /* Infographic */
    292. 

  292.   .infographic {
    293. 

  293.     display: grid;
    294. 

  294.     grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));
    295. 

  295.     gap: 1rem;
    296. 

  296.     margin: 1.5rem 0;
    297. 

  297.   }
    298. 

  298.   .info-item {
    299. 

  299.     text-align: center;
    300. 

  300.     padding: 1.5rem 1rem;
    301. 

  301.     background: white;
    302. 

  302.     border-radius: var(--radius);
    303. 

  303.     border: 1px solid #e2e8f0;
    304. 

  304.   }
    305. 

  305.   .info-item .icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    306. 

  306.   .info-item h4 { font-size: 0.9rem; font-weight: 600; margin-bottom: 0.3rem; }
    307. 

  307.   .info-item p { font-size: 0.8rem; color: var(--text-muted); margin: 0; }
    308. 

  308. 

  309.   /* Compare Table */
    310. 

  310.   .compare-table {
    311. 

  311.     width: 100%;
    312. 

  312.     border-collapse: collapse;
    313. 

  313.     margin: 1.5rem 0;
    314. 

  314.     font-size: 0.9rem;
    315. 

  315.     background: white;
    316. 

  316.     border-radius: var(--radius);
    317. 

  317.     overflow: hidden;
    318. 

  318.     box-shadow: var(--shadow-card);
    319. 

  319.   }
    320. 

  320.   .compare-table th {
    321. 

  321.     background: var(--bg-dark);
    322. 

  322.     color: white;
    323. 

  323.     padding: 0.75rem 1rem;
    324. 

  324.     text-align: left;
    325. 

  325.     font-weight: 600;
    326. 

  326.   }
    327. 

  327.   .compare-table td { padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; }
    328. 

  328.   .compare-table tr:last-child td { border-bottom: none; }
    329. 

  329.   .compare-table .highlight-cell { background: var(--green-light); font-weight: 600; }
    330. 

  330. 

  331.   /* Mechanism Diagram */
    332. 

  332.   .mechanism-diagram {
    333. 

  333.     margin: 2rem 0;
    334. 

  334.     text-align: center;
    335. 

  335.   }
    336. 

  336.   .mechanism-diagram img {
    337. 

  337.     max-width: 100%;
    338. 

  338.     border-radius: var(--radius);
    339. 

  339.     box-shadow: var(--shadow-card);
    340. 

  340.     border: 1px solid #e2e8f0;
    341. 

  341.   }
    342. 

  342.   .mechanism-diagram .diagram-caption {
    343. 

  343.     font-size: 0.8rem;
    344. 

  344.     color: var(--text-muted);
    345. 

  345.     margin-top: 0.75rem;
    346. 

  346.     line-height: 1.6;
    347. 

  347.     text-align: left;
    348. 

  348.     background: var(--bg-alt);
    349. 

  349.     border-radius: 8px;
    350. 

  350.     padding: 0.75rem 1rem;
    351. 

  351.   }
    352. 

  352.   .mechanism-diagram .diagram-caption strong { color: var(--accent); }
    353. 

  353. 

  354.   /* Screenshot with annotation */
    355. 

  355.   .screenshot-block {
    356. 

  356.     margin: 1.5rem 0;
    357. 

  357.   }
    358. 

  358.   .screenshot-block img {
    359. 

  359.     width: 100%;
    360. 

  360.     max-height: 480px;
    361. 

  361.     object-fit: cover;
    362. 

  362.     object-position: top;
    363. 

  363.     border-radius: var(--radius);
    364. 

  364.     border: 1px solid #e2e8f0;
    365. 

  365.     box-shadow: var(--shadow-card);
    366. 

  366.   }
    367. 

  367.   .screenshot-block .screenshot-note {
    368. 

  368.     font-size: 0.78rem;
    369. 

  369.     color: var(--text-muted);
    370. 

  370.     margin-top: 0.4rem;
    371. 

  371.     line-height: 1.6;
    372. 

  372.   }
    373. 

  373.   .screenshot-block .screenshot-note a { color: var(--blue); }
    374. 

  374. 

  375.   /* Footer */
    376. 

  376.   .site-footer {
    377. 

  377.     background: var(--bg-dark);
    378. 

  378.     color: #fff;
    379. 

  379.     padding: 3rem 0 0;
    380. 

  380.   }
    381. 

  381.   .footer-inner {
    382. 

  382.     display: flex;
    383. 

  383.     justify-content: space-between;
    384. 

  384.     gap: 3rem;
    385. 

  385.     padding-bottom: 2rem;
    386. 

  386.     border-bottom: 1px solid rgba(255,255,255,.1);
    387. 

  387.     flex-wrap: wrap;
    388. 

  388.   }
    389. 

  389.   .footer-brand .logo-text {
    390. 

  390.     color: #fff;
    391. 

  391.     font-size: 1.25rem;
    392. 

  392.     font-weight: 700;
    393. 

  393.   }
    394. 

  394.   .footer-brand .logo-tag {
    395. 

  395.     color: var(--accent);
    396. 

  396.     font-weight: 600;
    397. 

  397.   }
    398. 

  398.   .footer-brand p {
    399. 

  399.     color: rgba(255,255,255,.6);
    400. 

  400.     font-size: 0.85rem;
    401. 

  401.     margin-top: 0.5rem;
    402. 

  402.     max-width: 300px;
    403. 

  403.     line-height: 1.7;
    404. 

  404.   }
    405. 

  405.   .footer-links {
    406. 

  406.     display: flex;
    407. 

  407.     gap: 3rem;
    408. 

  408.     flex-wrap: wrap;
    409. 

  409.   }
    410. 

  410.   .footer-col h4 {
    411. 

  411.     font-size: 0.75rem;
    412. 

  412.     font-weight: 600;
    413. 

  413.     text-transform: uppercase;
    414. 

  414.     letter-spacing: .06em;
    415. 

  415.     color: rgba(255,255,255,.5);
    416. 

  416.     margin-bottom: 1rem;
    417. 

  417.   }
    418. 

  418.   .footer-col ul { list-style: none; }
    419. 

  419.   .footer-col ul li { margin-bottom: 0.5rem; }
    420. 

  420.   .footer-col ul li a {
    421. 

  421.     font-size: 0.85rem;
    422. 

  422.     color: rgba(255,255,255,.7);
    423. 

  423.     transition: color 0.2s;
    424. 

  424.     text-decoration: none;
    425. 

  425.   }
    426. 

  426.   .footer-col ul li a:hover { color: var(--accent); }
    427. 

  427.   .footer-contact li {
    428. 

  428.     font-size: 0.85rem;
    429. 

  429.     color: rgba(255,255,255,.6);
    430. 

  430.     line-height: 1.8;
    431. 

  431.   }
    432. 

  432.   .footer-contact li a { color: rgba(255,255,255,.7); }
    433. 

  433.   .footer-bottom {
    434. 

  434.     text-align: center;
    435. 

  435.     padding: 1.5rem 0;
    436. 

  436.   }
    437. 

  437.   .footer-bottom p {
    438. 

  438.     font-size: 0.75rem;
    439. 

  439.     color: rgba(255,255,255,.4);
    440. 

  440.   }
    441. 

  441.   .footer-logo-img {
    442. 

  442.     display: block;
    443. 

  443.     flex-shrink: 0;
    444. 

  444.     border-radius: 10px;
    445. 

  445.     margin-bottom: 0.5rem;
    446. 

  446.     object-fit: contain;
    447. 

  447.   }
    448. 

  448.   .footer-legal {
    449. 

  449.     margin-top: 0.3rem;
    450. 

  450.     font-size: 0.75rem;
    451. 

  451.     color: rgba(255,255,255,.4);
    452. 

  452.     display: flex;
    453. 

  453.     gap: 1rem;
    454. 

  454.     justify-content: center;
    455. 

  455.     flex-wrap: wrap;
    456. 

  456.   }
    457. 

  457.   .footer-legal a {
    458. 

  458.     color: rgba(255,255,255,.4);
    459. 

  459.     text-decoration: underline;
    460. 

  460.   }
    461. 

  461.   .footer-legal a:hover { color: var(--accent); }
    462. 

  462. 

  463.   /* Ref link icon */
    464. 

  464.   .ref-link-icon {
    465. 

  465.     display: inline-flex;
    466. 

  466.     align-items: center;
    467. 

  467.     gap: 0.3rem;
    468. 

  468.     font-size: 0.8rem;
    469. 

  469.     color: var(--blue);
    470. 

  470.     text-decoration: none;
    471. 

  471.     margin-right: 1rem;
    472. 

  472.   }
    473. 

  473.   .ref-link-icon:hover { text-decoration: underline; }
    474. 

  474. 

  475.   /* Authority badge — 引用权威性标签 */
    476. 

  476.   .authority-badge {
    477. 

  477.     display: inline-flex;
    478. 

  478.     align-items: center;
    479. 

  479.     gap: 0.35rem;
    480. 

  480.     font-size: 0.75rem;
    481. 

  481.     padding: 0.2rem 0.6rem;
    482. 

  482.     border-radius: 999px;
    483. 

  483.     background: #e8f5e9;
    484. 

  484.     color: #2e7d32;
    485. 

  485.     border: 1px solid #a5d6a7;
    486. 

  486.     font-weight: 500;
    487. 

  487.     white-space: nowrap;
    488. 

  488.   }
    489. 

  489.   .authority-badge.high { background: #e3f2fd; color: #1565c0; border-color: #90caf9; }
    490. 

  490.   .authority-badge.medium { background: #fff3e0; color: #e65100; border-color: #ffcc80; }
    491. 

  491.   .authority-badge.review { background: #f3e5f5; color: #7b1fa2; border-color: #ce93d8; }
    492. 

  492.   .authority-badge.rct { background: #e8f5e9; color: #2e7d32; border-color: #a5d6a7; }
    493. 

  493.   .authority-badge.animal { background: #fce4ec; color: #c62828; border-color: #ef9a9a; }
    494. 

  494.   .authority-badge.concept { background: #fff8e1; color: #f57f17; border-color: #ffe082; }
    495. 

  495. 

  496.   /* Evidence screenshot thumbnail */
    497. 

  497.   .evidence-thumb {
    498. 

  498.     display: inline-block;
    499. 

  499.     margin: 0.5rem 0 0.3rem;
    500. 

  500.     border-radius: 8px;
    501. 

  501.     overflow: hidden;
    502. 

  502.     max-width: 100%;
    503. 

  503.     border: 1px solid #e2e8f0;
    504. 

  504.     box-shadow: 0 2px 8px rgba(0,0,0,0.06);
    505. 

  505.     transition: box-shadow 0.2s;
    506. 

  506.     cursor: zoom-in;
    507. 

  507.   }
    508. 

  508.   .evidence-thumb:hover { box-shadow: 0 4px 16px rgba(0,0,0,0.12); }
    509. 

  509.   .evidence-thumb img { display: block; max-width: 100%; height: auto; max-height: 200px; }
    510. 

  510.   .evidence-thumb-label {
    511. 

  511.     display: block;
    512. 

  512.     font-size: 0.7rem;
    513. 

  513.     color: #9ca3af;
    514. 

  514.     text-align: center;
    515. 

  515.     padding: 0.2rem;
    516. 

  516.     background: #f9fafb;
    517. 

  517.     border-top: 1px solid #f3f4f6;
    518. 

  518.   }
    519. 

  519. 

  520.   /* 英文→中文翻译 */
    521. 

  521.   .translation {
    522. 

  522.     display: block;
    523. 

  523.     font-size: 0.82rem;
    524. 

  524.     color: var(--blue);
    525. 

  525.     margin-top: 0.2rem;
    526. 

  526.     padding: 0.3rem 0.5rem;
    527. 

  527.     background: #f0f7ff;
    528. 

  528.     border-radius: 4px;
    529. 

  529.     border-left: 3px solid var(--blue);
    530. 

  530.   }
    531. 

  531.   .translation::before {
    532. 

  532.     content: "📖 中文翻译：";
    533. 

  533.     font-weight: 600;
    534. 

  534.     margin-right: 0.3rem;
    535. 

  535.   }
    536. 

  536. 

  537.   /* Citation card enhancement */
    538. 

  538.   .citation-card {
    539. 

  539.     position: relative;
    540. 

  540.   }
    541. 

  541.   .citation-card .authority-row {
    542. 

  542.     display: flex;
    543. 

  543.     flex-wrap: wrap;
    544. 

  544.     align-items: center;
    545. 

  545.     gap: 0.5rem;
    546. 

  546.     margin: 0.5rem 0 0.3rem;
    547. 

  547.   }
    548. 

  548. 

  549.   /* Ref list */
    550. 

  550.   .ref-list {
    551. 

  551.     font-size: 0.85rem;
    552. 

  552.     line-height: 2;
    553. 

  553.     color: var(--text-muted);
    554. 

  554.   }
    555. 

  555.   .ref-list a { color: var(--blue); text-decoration: none; }
    556. 

  556.   .ref-list a:hover { text-decoration: underline; }
    557. 

  557.   .ref-list li { margin-bottom: 0.3rem; }
    558. 

  558. 

  559.   /* Inline annotated evidence screenshot */
    560. 

  560.   .evidence-inline {
    561. 

  561.     margin: 1.5rem 0;
    562. 

  562.     padding: 1rem;
    563. 

  563.     background: #f8fafc;
    564. 

  564.     border: 1px solid #e2e8f0;
    565. 

  565.     border-radius: var(--radius);
    566. 

  566.     box-shadow: var(--shadow-card);
    567. 

  567.   }
    568. 

  568.   .evidence-inline .evidence-title {
    569. 

  569.     font-size: 0.9rem;
    570. 

  570.     font-weight: 600;
    571. 

  571.     color: var(--text-primary);
    572. 

  572.     margin-bottom: 0.6rem;
    573. 

  573.     display: flex;
    574. 

  574.     align-items: center;
    575. 

  575.     gap: 0.4rem;
    576. 

  576.   }
    577. 

  577.   .evidence-inline .evidence-image-wrap {
    578. 

  578.     position: relative;
    579. 

  579.     display: inline-block;
    580. 

  580.     max-width: 100%;
    581. 

  581.     border-radius: 8px;
    582. 

  582.     overflow: hidden;
    583. 

  583.     border: 1px solid #e2e8f0;
    584. 

  584.   }
    585. 

  585.   .evidence-inline .evidence-image-wrap img {
    586. 

  586.     display: block;
    587. 

  587.     max-width: 100%;
    588. 

  588.     height: auto;
    589. 

  589.     max-height: 220px;
    590. 

  590.   }
    591. 

  591.   .evidence-inline .evidence-highlight {
    592. 

  592.     position: absolute;
    593. 

  593.     top: 18%;
    594. 

  594.     left: 4%;
    595. 

  595.     width: 92%;
    596. 

  596.     height: 28%;
    597. 

  597.     border: 3px dashed #e53e3e;
    598. 

  598.     background: rgba(229, 62, 62, 0.06);
    599. 

  599.     border-radius: 6px;
    600. 

  600.     pointer-events: none;
    601. 

  601.   }
    602. 

  602.   .evidence-inline .evidence-highlight::after {
    603. 

  603.     content: "🔍 关键发现";
    604. 

  604.     position: absolute;
    605. 

  605.     top: -22px;
    606. 

  606.     left: 0;
    607. 

  607.     background: #e53e3e;
    608. 

  608.     color: white;
    609. 

  609.     font-size: 0.7rem;
    610. 

  610.     padding: 0.15rem 0.5rem;
    611. 

  611.     border-radius: 4px;
    612. 

  612.     font-weight: 600;
    613. 

  613.   }
    614. 

  614.   .evidence-inline .evidence-caption {
    615. 

  615.     margin-top: 0.75rem;
    616. 

  616.     font-size: 0.85rem;
    617. 

  617.     color: var(--text-secondary);
    618. 

  618.     line-height: 1.6;
    619. 

  619.   }
    620. 

  620.   .evidence-inline .evidence-translation {
    621. 

  621.     margin-top: 0.5rem;
    622. 

  622.     padding: 0.5rem 0.7rem;
    623. 

  623.     background: #f0f7ff;
    624. 

  624.     border-left: 3px solid var(--blue);
    625. 

  625.     border-radius: 0 6px 6px 0;
    626. 

  626.     font-size: 0.82rem;
    627. 

  627.     color: var(--blue);
    628. 

  628.   }
    629. 

  629.   .evidence-inline .evidence-meta {
    630. 

  630.     margin-top: 0.6rem;
    631. 

  631.     font-size: 0.8rem;
    632. 

  632.     color: var(--text-muted);
    633. 

  633.   }
    634. 

  634.   .evidence-inline .evidence-meta a {
    635. 

  635.     color: var(--blue);
    636. 

  636.     text-decoration: none;
    637. 

  637.   }
    638. 

  638.   .evidence-inline .evidence-meta a:hover { text-decoration: underline; }
    639. 

  639. 

  640.   /* Warning box */
    641. 

  641.   .warning { background: #fff8e1; border-left: 4px solid #f39c12; padding: 0.8rem 1rem; border-radius: 0 6px 6px 0; margin: 1rem 0; font-size: 0.9rem; }
    642. 

  642. 

  643.   /* Responsive */
    644. 

  644.   @media (max-width: 640px) {
    645. 

  645.     .hero { padding: 4rem 1rem 3rem; min-height: auto; }
    646. 

  646.     .hero-stats { gap: 0.75rem; }
    647. 

  647.     .hero-stat { min-width: 100px; padding: 0.75rem 1rem; }
    648. 

  648.     .hero-stat .num { font-size: 1.3rem; }
    649. 

  649.     .data-grid { grid-template-columns: 1fr; }
    650. 

  650.     .two-col-grid { grid-template-columns: 1fr; }
    651. 

  651.     .two-col-grid-3 { grid-template-columns: 1fr; }
    652. 

  652.     .tip-grid { grid-template-columns: 1fr; }
    653. 

  653.     section { padding: 2.5rem 0; }
    654. 

  654.     h2 { font-size: 1.4rem; }
    655. 

  655.     .highlight-box { padding: 1.25rem; }
    656. 

  656.     .compare-table { font-size: 0.8rem; }
    657. 

  657.     .compare-table th, .compare-table td { padding: 0.5rem 0.75rem; }
    658. 

  658.   }
    659. 

  659. </style>
    660. 

  660. </head>
    661. 

  661. <body>
    662. 

  662. 

  663. <!-- ===== HERO ===== -->
    664. 

  664. <header class="hero">
    665. 

  665.   <div class="hero-particles">
    666. 

  666.     <div class="particle"></div><div class="particle"></div><div class="particle"></div>
    667. 

  667.     <div class="particle"></div><div class="particle"></div><div class="particle"></div>
    668. 

  668.     <div class="particle"></div>
    669. 

  669.   </div>
    670. 

  670.   <div class="hero-content">
    671. 

  671.     <div class="hero-badge">🧠 科学循证 · 2024-2026最新研究</div>
    672. 

  672.     <h1>老年痴呆 - 神经炎症、肠脑轴与主动健康</h1>
    673. 

  673.     <p>Aβ斑块在症状出现前15年就开始沉积。老年痴呆的本质是大脑的慢性神经炎症——肠脑轴失调是小胶质细胞失控的根源。</p>
    674. 

  674.     <div class="hero-stats">
    675. 

  675.       <div class="hero-stat">
    676. 

  676.         <span class="num">1.7亿</span>
    677. 

  677.         <span class="label">全球阿尔茨海默病患者</span>
    678. 

  678.       </div>
    679. 

  679.       <div class="hero-stat">
    680. 

  680.         <span class="num">65%</span>
    681. 

  681.         <span class="label">神经炎症相关发病机制</span>
    682. 

  682.       </div>
    683. 

  683.       <div class="hero-stat">
    684. 

  684.         <span class="num">15年</span>
    685. 

  685.         <span class="label">症状出现前病理积累</span>
    686. 

  686.       </div>
    687. 

  687.       <div class="hero-stat">
    688. 

  688.         <span class="num">3-4倍</span>
    689. 

  689.         <span class="label">TREM2突变风险增加</span>
    690. 

  690.       </div>
    691. 

  691.     </div>
    692. 

  692.   </div>
    693. 

  693. </header>
    694. 

  694. 

  695. <!-- ===== TOC ===== -->
    696. 

  696. <nav class="toc">
    697. 

  697.   <div class="toc-inner">
    698. 

  698.     <a href="#symptoms">症</a>
    699. 

  699.     <a href="#causes">因</a>
    700. 

  700.     <a href="#step1">STEP 01</a>
    701. 

  701.     <a href="#step2">STEP 02</a>
    702. 

  702.     <a href="#step3">STEP 03</a>
    703. 

  703.     <a href="#step4">STEP 04</a>
    704. 

  704.     <a href="#step5">STEP 05</a>
    705. 

  705.     <a href="#references">参考文献</a>
    706. 

  706.   </div>
    707. 

  707. </nav>
    708. 

  708. 

  709. <!-- ===== SECTION: SYMPTOMS ===== -->
    710. 

  710. <section id="symptoms">
    711. 

  711.   <div class="container">
    712. 

  712.     <h2>🧠 不要等发现症状才开始重视</h2>
    713. 

  713.     
    714. 

  714.     <p>当记忆力下降到影响日常生活的程度时，大脑已经有10-20年的病理积累了。Aβ淀粉样斑块在症状出现前15-20年就开始沉积，tau蛋白缠结在确诊前10年就已蔓延。</p>
    715. 

  715.     
    716. 

  716.     <p><strong>典型认知症状（病理已广泛的标志）：</strong></p>
    717. 

  717.     <ul>
    718. 

  718.       <li>近记忆障碍：无法新近学习的信息保持在记忆中</li>
    719. 

  719.       <li>失语：语言表达或理解能力下降</li>
    720. 

  720.       <li>失用：无法计划或执行日常动作</li>
    721. 

  721.       <li>失认：无法识别熟悉的物品或面孔</li>
    722. 

  722.     </ul>
    723. 

  723.     
    724. 

  724.     <div class="highlight-box blue">
    725. 

  725.       <p><strong>正常老化vs痴呆：</strong>正常老化偶尔忘事但能回忆，痴呆是越来越记不住且无法通过提醒回忆。</p>
    726. 

  726.     </div>
    727. 

  727.     
    728. 

  728.     <div class="warning">
    729. 

  729.       <b>⚠️ 早期识别：</b>一旦出现上述症状，请及时进行MoCA认知评估和神经影像学检查，以排除或确诊阿尔茨海默病。
    730. 

  730.     </div>
    731. 

  731.   </div>
    732. 

  732. </section>
    733. 

  733. 

  734. <!-- ===== SECTION: CAUSES ===== -->
    735. 

  735. <section id="causes" class="alt">
    736. 

  736.   <div class="container">
    737. 

  737.     <h2>🧬阿尔茨海默病本质是大脑的"慢性炎症"</h2>
    738. 

  738.     
    739. 

  739.     <div class="highlight-box purple">
    740. 

  740.       <p><strong>核心论点：</strong>阿尔茨海默病本质是大脑的"慢性炎症"——肠道菌群失调通过肠脑轴驱动神经炎症，小胶质细胞从保护者变成破坏者。</p>
    741. 

  741.     </div>
    742. 

  742.     
    743. 

  743.     <h3>1. Aβ-Tau蛋白之外：炎症才是核心</h3>
    744. 

  744.     
    745. 

  745.     <p>Aβ淀粉样斑块和tau蛋白缠结是阿尔茨海默病（AD）的病理标志，但针对Aβ的药物（如Aducanumab、Lecanemab）临床获益有限。越来越多的证据支持：神经炎症（神经胶质细胞过度激活）是比Aβ/Tau更核心的损伤机制。</p>
    746. 

  746.     
    747. 

  747.     <div class="two-col-grid">
    748. 

  748.       <div class="citation-card" style="border-left:4px solid #805ad5;">
    749. 

  749.         <div class="source">🧬 小胶质细胞的"双面角色"</div>
    750. 

  750.         <div class="findings">
    751. 

  751.           <strong>保护状态（A1表型）：</strong>清除Aβ碎片、修剪不必要的突触（神经发育期正常，AD中失调）<br><br>
    752. 

  752.           <strong>破坏状态（持续激活）：</strong>分泌IL-1β/IL-6/TNF-α/补体→杀死神经元、促进tau磷酸化→突触丢失<br><br>
    753. 

  753.           <strong>TREM2基因突变：</strong>小胶质细胞吞噬能力↓→Aβ清除↓→AD风险↑3-4倍<br><br>
    754. 

  754.           <strong>靶向小胶质细胞抗炎治疗：</strong>成为新的研究热点
    755. 

  755.         </div>
    756. 

  756.       </div>
    757. 

  757.       <div class="citation-card" style="border-left:4px solid #dd6b20;">
    758. 

  758.         <div class="source">⚠️ 临床证据</div>
    759. 

  759.         <div class="findings">
    760. 

  760.           Lecanemab（抗Aβ单克隆抗体）临床获益有限，ARIA风险高<br>
    761. 

  761.           针对神经炎症的药物（如托珠单抗、司库尼布）正在进行临床试验<br>
    762. 

  762.           小胶质细胞状态与AD进展相关性强于Aβ/Tau负荷
    763. 

  763.         </div>
    764. 

  764.       </div>
    765. 

  765.     </div>
    766. 

  766.     
    767. 

  767.     <h3>2. 肠脑轴（Gut-Brain Axis）——肠道炎症→神经炎症</h3>
    768. 

  768.     
    769. 

  769.     <p>肠道与大脑通过神经、免疫、代谢三条途径双向连接。肠道菌群失调→肠漏→LPS进入血液→系统性炎症→血脑屏障通透性↑→大脑小胶质细胞激活。</p>
    770. 

  770.     
    771. 

  771.     <div class="mechanism-diagram">
    772. 

  772.       <svg viewBox="0 0 860 540" xmlns="http://www.w3.org/2000/svg" style="max-width:100%;border-radius:var(--radius);box-shadow:var(--shadow-card);border:1px solid #e2e8f0;background:#fff;">
    773. 

  773.         <!-- Gut (left side) -->
    774. 

  774.         <rect x="30" y="40" width="180" height="200" rx="12" fill="#f0fdf4" stroke="#22c55e" stroke-width="2"/>
    775. 

  775.         <text x="120" y="80" text-anchor="middle" font-size="14" font-weight="700" fill="#166534">肠道 (Gut)</text>
    776. 

  776.         <rect x="50" y="100" width="140" height="40" rx="6" fill="#dcfce7" stroke="#86efac" stroke-width="1"/>
    777. 

  777.         <text x="120" y="125" text-anchor="middle" font-size="11" fill="#15803d">菌群失调 Dysbiosis</text>
    778. 

  778.         <rect x="50" y="150" width="140" height="40" rx="6" fill="#fef2f2" stroke="#fca5a5" stroke-width="1"/>
    779. 

  779.         <text x="120" y="175" text-anchor="middle" font-size="11" fill="#b91c1c">肠漏 Leaky Gut</text>
    780. 

  780.         <text x="120" y="220" text-anchor="middle" font-size="11" fill="#64748b">产丁酸菌↓</text>
    781. 

  781.         <text x="120" y="238" text-anchor="middle" font-size="11" fill="#64748b">促炎菌↑</text>
    782. 

  782. 

  783.         <!-- Gut Microbes icons -->
    784. 

  784.         <circle cx="80" y="260" r="6" fill="#ef4444" opacity="0.6"/>
    785. 

  785.         <circle cx="100" y="270" r="4" fill="#ef4444" opacity="0.5"/>
    786. 

  786.         <circle cx="120" y="258" r="5" fill="#ef4444" opacity="0.7"/>
    787. 

  787.         <circle cx="145" y="268" r="5" fill="#ef4444" opacity="0.6"/>
    788. 

  788.         <text x="120" y="290" text-anchor="middle" font-size="9" fill="#94a3b8">致病菌 ↑</text>
    789. 

  789. 

  790.         <!-- LPS arrow -->
    791. 

  791.         <defs>
    792. 

  792.           <marker id="arrowRed" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    793. 

  793.             <polygon points="0,0 10,4 0,8" fill="#ef4444"/>
    794. 

  794.           </marker>
    795. 

  795.           <marker id="arrowGreen" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    796. 

  796.             <polygon points="0,0 10,4 0,8" fill="#22c55e"/>
    797. 

  797.           </marker>
    798. 

  798.           <marker id="arrowBlue" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    799. 

  799.             <polygon points="0,0 10,4 0,8" fill="#3b82f6"/>
    800. 

  800.           </marker>
    801. 

  801.           <marker id="arrowPurple" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    802. 

  802.             <polygon points="0,0 10,4 0,8" fill="#8b5cf6"/>
    803. 

  803.           </marker>
    804. 

  804.         </defs>
    805. 

  805. 

  806.         <!-- LPS Leakage -->
    807. 

  807.         <line x1="230" y1="140" x2="340" y2="140" stroke="#ef4444" stroke-width="2.5" marker-end="url(#arrowRed)" stroke-dasharray="6,3"/>
    808. 

  808.         <text x="285" y="130" text-anchor="middle" font-size="9" fill="#ef4444">LPS 入血</text>
    809. 

  809. 

  810.         <!-- Systemic Circulation -->
    811. 

  811.         <rect x="340" y="100" width="140" height="80" rx="10" fill="#f0f9ff" stroke="#3b82f6" stroke-width="1.5"/>
    812. 

  812.         <text x="410" y="135" text-anchor="middle" font-size="12" font-weight="600" fill="#1d4ed8">血液系统</text>
    813. 

  813.         <text x="410" y="158" text-anchor="middle" font-size="9" fill="#64748b">系统性炎症 ↑</text>
    814. 

  814. 

  815.         <!-- Blood-Brain Barrier -->
    816. 

  816.         <line x1="480" y1="120" x2="580" y2="120" stroke="#f59e0b" stroke-width="2" marker-end="url(#arrowRed)"/>
    817. 

  817.         <text x="530" y="112" text-anchor="middle" font-size="9" fill="#f59e0b">BBB 通透性 ↑</text>
    818. 

  818. 

  819.         <!-- Brain side -->
    820. 

  820.         <rect x="580" y="40" width="240" height="220" rx="12" fill="#faf5ff" stroke="#8b5cf6" stroke-width="2"/>
    821. 

  821.         <text x="700" y="80" text-anchor="middle" font-size="14" font-weight="700" fill="#6b21a8">大脑 (Brain)</text>
    822. 

  822. 

  823.         <!-- Microglia -->
    824. 

  824.         <rect x="600" y="100" width="200" height="50" rx="8" fill="#ede9fe" stroke="#c4b5fd" stroke-width="1"/>
    825. 

  825.         <text x="700" y="130" text-anchor="middle" font-size="12" font-weight="600" fill="#5b21b6">小胶质细胞过度激活</text>
    826. 

  826. 

  827.         <!-- TLR4 -->
    828. 

  828.         <rect x="610" y="160" width="80" height="30" rx="6" fill="#fef2f2" stroke="#fca5a5" stroke-width="1"/>
    829. 

  829.         <text x="650" y="179" text-anchor="middle" font-size="10" fill="#b91c1c">TLR4 通路</text>
    830. 

  830.         <line x1="650" y1="130" x2="650" y2="160" stroke="#8b5cf6" stroke-width="1.5" marker-end="url(#arrowPurple)"/>
    831. 

  831. 

  832.         <!-- SCFAs arrow from gut to BBB -->
    833. 

  833.         <line x1="140" y1="130" x2="140" y2="30" stroke="#22c55e" stroke-width="1.5" marker-end="url(#arrowGreen)" stroke-dasharray="4,4"/>
    834. 

  834.         <text x="155" y="55" font-size="9" fill="#22c55e">SCFAs 保护信号 ↓</text>
    835. 

  835. 

  836.         <!-- Neuroinflammation output -->
    837. 

  837.         <rect x="610" y="200" width="180" height="50" rx="8" fill="#fee2e2" stroke="#fecaca" stroke-width="1"/>
    838. 

  838.         <text x="700" y="225" text-anchor="middle" font-size="11" font-weight="600" fill="#b91c1c">神经炎症 Neuroinflammation</text>
    839. 

  839.         <text x="700" y="242" text-anchor="middle" font-size="9" fill="#dc2626">Aβ↑ τ↑ Tau磷酸化↑</text>
    840. 

  840.         <line x1="700" y1="130" x2="700" y2="200" stroke="#ef4444" stroke-width="2" marker-end="url(#arrowRed)"/>
    841. 

  841. 

  842.         <!-- Molecules legend -->
    843. 

  843.         <rect x="30" y="310" width="790" height="80" rx="10" fill="#f8fafc" stroke="#e2e8f0" stroke-width="1"/>
    844. 

  844.         <text x="50" y="335" font-size="11" font-weight="600" fill="#334155">关键分子:</text>
    845. 

  845.         <line x1="130" y1="332" x2="170" y2="332" stroke="#ef4444" stroke-width="2"/>
    846. 

  846.         <text x="175" y="338" font-size="10" fill="#475569">LPS / 内毒素 —</text>
    847. 

  847.         <line x1="270" y1="332" x2="310" y2="332" stroke="#22c55e" stroke-width="2"/>
    848. 

  848.         <text x="315" y="338" font-size="10" fill="#475569">SCFAs / 丁酸 —</text>
    849. 

  849.         <line x1="410" y1="332" x2="450" y2="332" stroke="#8b5cf6" stroke-width="2"/>
    850. 

  850.         <text x="455" y="338" font-size="10" fill="#475569">TLR4 —</text>
    851. 

  851.         <line x1="530" y1="332" x2="570" y2="332" stroke="#3b82f6" stroke-width="2"/>
    852. 

  852.         <text x="575" y="338" font-size="10" fill="#475569">血脑屏障 BBB</text>
    853. 

  853.         <text x="50" y="362" font-size="10" fill="#94a3b8">路径: 菌群失调 → 肠漏 → LPS入血 → TLR4激活 → 小胶质细胞M1极化 → IL-1β/IL-6/TNF-α释放 → 神经炎症 → Aβ加速沉积 + tau过度磷酸化</text>
    854. 

  854.         <text x="50" y="380" font-size="10" fill="#94a3b8">保护路径: 健康菌群 → SCFAs(丁酸)↑ → 血脑屏障完整性↑ → 小胶质细胞维持M2保护表型 → Aβ有效清除</text>
    855. 

  855. 

  856.         <!-- Key connection arrows -->
    857. 

  857.         <line x1="230" y1="170" x2="340" y2="170" stroke="#ef4444" stroke-width="2.5" marker-end="url(#arrowRed)"/>
    858. 

  858.         <line x1="480" y1="140" x2="580" y2="140" stroke="#ef4444" stroke-width="2" marker-end="url(#arrowRed)"/>
    859. 

  859.       </svg>
    860. 

  860.       <div class="diagram-caption">
    861. 

  861.         <strong>▲ 图1：肠脑轴机制图</strong><br>
    862. 

  862.         肠道菌群失调→肠漏→LPS进入血液→系统性炎症→血脑屏障通透性↑→大脑小胶质细胞激活→神经炎症→AD<br>
    863. 

  863.         <strong>关键分子：</strong>SCFAs（丁酸）→调节小胶质细胞成熟和功能；LPS→通过TLR4激活小胶质细胞<br>
    864. 

  864.         <strong>参考文献：</strong>Lancet 2020 dementia commission doi:10.1016/S0140-6736(20)30367-6；Nature Neuroscience 2019
    865. 

  865.       </div>
    866. 

  866.     </div>
    867. 

  867.     
    868. 

  868.     <div class="citation-card">
    869. 

  869.       <div class="source">📊 AD患者肠道菌群特征</div>
    870. 

  870.       <div class="findings">
    871. 

  871.         AD患者肠道菌群特征：产丁酸菌（Akkermansia、Faecalibacterium）↓，产促炎菌（Escherichia、Shigella）↑<br>
    872. 

  872.         <strong>Nature Neuroscience 2019：</strong>AD患者的肠道菌群移植到小鼠→Aβ沉积↑、认知障碍↑（无菌小鼠对Aβ沉积抵抗）→肠道菌群是AD的因果因素
    873. 

  873.       </div>
    874. 

  874.     </div>
    875. 

  875. 

  876.     <div class="evidence-inline">
    877. 

  877.       <div class="evidence-title">🧬 证据截图 — 肠道菌群驱动AD的关键研究</div>
    878. 

  878.       <div class="evidence-image-wrap">
    879. 

  879.         <img src="../img/ref-screenshots/gut-microbiome-damage.jpg" alt="肠道菌群失调与AD关系截图" loading="lazy">
    880. 

  880.       </div>
    881. 

  881.       <div class="evidence-caption">
    882. 

  882.         <strong>金标准CANTOS RCT</strong>：靶向IL-1β的抗炎治疗使肺癌风险降低67% (Ridker et al., NEJM 2017)。这一发现首次在人类RCT层面验证了"炎症→疾病"的因果关系——AD的神经炎症同理。
    883. 

  883.       </div>
    884. 

  884.       <div class="evidence-translation">
    885. 

  885.         📖 中文翻译：CANTOS实验证明，靶向抑制IL-1β（炎症核心因子）不仅降低心血管事件，还意外降低肺癌风险——这为"通过抗炎预防神经退行性疾病"提供了直接的人体证据。AD的神经炎症机制与此同理：IL-1β是小胶质细胞激活后的核心致病因子。
    886. 

  886.       </div>
    887. 

  887.       <div class="evidence-meta">
    888. 

  888.         来源：Ridker PM et al. "Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis" · <a href="https://doi.org/10.1056/NEJMoa1707914" target="_blank" rel="noopener">NEJM 2017 doi:10.1056/NEJMoa1707914</a>
    889. 

  889.       </div>
    890. 

  890.     </div>
    891. 

  891.     
    892. 

  892.     <h3>3. 小胶质细胞的"双面角色"</h3>
    893. 

  893.     
    894. 

  894.     <div class="infographic">
    895. 

  895.       <div class="info-item">
    896. 

  896.         <div class="icon">🛡️</div>
    897. 

  897.         <h4>保护状态</h4>
    898. 

  898.         <p>A1表型<br>清除Aβ碎片<br>突触修剪</p>
    899. 

  899.       </div>
    900. 

  900.       <div class="info-item">
    901. 

  901.         <div class="icon">⚡</div>
    902. 

  902.         <h4>破坏状态</h4>
    903. 

  903.         <p>持续激活<br>IL-1β/IL-6/TNF-α<br>tau磷酸化</p>
    904. 

  904.       </div>
    905. 

  905.       <div class="info-item">
    906. 

  906.         <div class="icon">🧬</div>
    907. 

  907.         <h4>TREM2突变</h4>
    908. 

  908.         <p>吞噬能力↓<br>Aβ清除↓<br>风险↑3-4倍</p>
    909. 

  909.       </div>
    910. 

  910.       <div class="info-item">
    911. 

  911.         <div class="icon">🎯</div>
    912. 

  912.         <h4>治疗靶点</h4>
    913. 

  913.         <p>抗炎治疗<br>小胶质细胞状态<br>神经炎症</p>
    914. 

  914.       </div>
    915. 

  915.     </div>
    916. 

  916.     
    917. 

  917.     <div class="evidence-inline">
    918. 

  918.       <div class="evidence-title">🧠 证据截图 — 小胶质细胞在AD中的双面角色</div>
    919. 

  919.       <div class="evidence-image-wrap">
    920. 

  920.         <img src="../img/ref-screenshots/ref3_nature_stt.png" alt="Nature综述：神经炎症与AD机制截图" loading="lazy">
    921. 

  921.       </div>
    922. 

  922.       <div class="evidence-caption">
    923. 

  923.         <strong>Nature Reviews Neurology 2021综述：</strong>神经炎症不是AD的被动结果，而是主动驱动因素。小胶质细胞从稳态向"疾病相关小胶质细胞(DAM)"表型转变是AD早期的关键事件——发生在Aβ大量沉积之前。TREM2突变携带者的小胶质细胞无法有效清除Aβ，且更容易进入破坏性的促炎状态。
    924. 

  924.       </div>
    925. 

  925.       <div class="evidence-translation">
    926. 

  926.         📖 中文翻译：小胶质细胞从保护者变为破坏者的过程是AD发病的核心环节。在Aβ斑块形成之前，炎症信号已经启动了小胶质细胞的功能转变。这意味着抗炎干预的最佳时机可能远在认知症状出现之前。
    927. 

  927.       </div>
    928. 

  928.       <div class="evidence-meta">
    929. 

  929.         来源：Leng F, Edison P. "Neuroinflammation and microglial activation in Alzheimer disease" · <a href="https://doi.org/10.1038/s41582-021-00453-y" target="_blank" rel="noopener">Nat Rev Neurol 2021doi:10.1038/s41582-021-00453-y</a>
    930. 

  930.       </div>
    931. 

  931.     </div>
    932. 

  932. 

  933.     <h3>4. 全身慢性炎症→神经退行性变</h3>
    934. 

  934.     
    935. 

  935.     <div class="two-col-grid-3">
    936. 

  936.       <div class="tip-card purple">
    937. 

  937.         <div class="tip-icon">🧬</div>
    938. 

  938.         <h4>CRP/IL-6水平升高</h4>
    939. 

  939.         <p>与AD风险正相关（meta分析：IL-6↑1SD→AD风险↑约30%）</p>
    940. 

  940.       </div>
    941. 

  941.       <div class="tip-card orange">
    942. 

  942.         <div class="icon">🫀</div>
    943. 

  943.         <h4>心血管病</h4>
    944. 

  944.         <p>动脉硬化→大脑慢性低灌注→血脑屏障功能↓→神经炎症↑</p>
    945. 

  945.       </div>
    946. 

  946.       <div class="tip-card blue">
    947. 

  947.         <div class="icon">🥊</div>
    948. 

  948.         <h4>糖尿病/胰岛素抵抗</h4>
    949. 

  949.         <p>AGEs积累→tau磷酸化↑→认知下降</p>
    950. 

  950.       </div>
    951. 

  951.       <div class="tip-card teal">
    952. 

  952.         <div class="icon">😴</div>
    953. 

  953.         <h4>睡眠剥夺</h4>
    954. 

  954.         <p>glymphatic系统↓→Aβ和tau的夜间清除↓→Aβ积累加速</p>
    955. 

  955.       </div>
    956. 

  956.     </div>
    957. 

  957.     
    958. 

  958.     <h3>5. 生活方式与AD风险</h3>
    959. 

  959.     
    960. 

  960.     <div class="tip-grid">
    961. 

  961.       <div class="tip-card green">
    962. 

  962.         <div class="tip-icon">🏃</div>
    963. 

  963.         <h4>缺乏运动</h4>
    964. 

  964.         <p>是最强可控风险因素之一（久坐→脑血流↓→神经炎症↑）</p>
    965. 

  965.       </div>
    966. 

  966.       <div class="tip-card orange">
    967. 

  967.         <div class="icon">🤝</div>
    968. 

  968.         <h4>社交孤立</h4>
    969. 

  969.         <p>小胶质细胞炎症模式改变→AD风险↑</p>
    970. 

  970.       </div>
    971. 

  971.       <div class="tip-card purple">
    972. 

  972.         <div class="icon">😤</div>
    973. 

  973.         <h4>抑郁/慢性应激</h4>
    974. 

  974.         <p>皮质醇↑→海马神经元萎缩</p>
    975. 

  975.       </div>
    976. 

  976.     </div>
    977. 

  977.     
    978. 

  978.     <h3>6. 氧化应激在AD中的作用</h3>
    979. 

  979.     
    980. 

  980.     <div class="highlight-box orange">
    981. 

  981.       <p><strong>Aβ诱导线粒体ROS↑→氧化应激→tau磷酸化↑→神经细胞死亡。</strong>大脑是体内耗氧量最高的器官（约占全身20%），抗氧化能力相对较弱。</p>
    982. 

  982.       <p><strong>富氢水：</strong>选择性清除·OH→氧化应激↓→可能减缓AD进程（目前主要是动物证据，人类研究有限但前景可期）<br><small style="color:var(--text-muted);">⚠ 富氢水的前提是水质安全——自来水中普遍检出抗生素和激素，需先净化后再电解。 → <a href="tap-water-pollution.html" style="color:var(--accent);">自来水中的隐形威胁</a></small></p>
    983. 

  983.     </div>
    984. 

  984. 

  985.     <div class="evidence-inline">
    986. 

  986.       <div class="evidence-title">💧 证据截图 — 富氢水抗氧化神经保护研究</div>
    987. 

  987.       <div class="evidence-image-wrap">
    988. 

  988.         <img src="../img/ref-screenshots/ref12_pmc_hydrogen_water.png" alt="氢水神经保护研究截图" loading="lazy">
    989. 

  989.       </div>
    990. 

  990.       <div class="evidence-caption">
    991. 

  991.         <strong>PMC综述 2024：</strong>分子氢(H₂)选择性清除羟基自由基(·OH)和过氧亚硝酸盐(ONOO⁻)，不干扰有益ROS信号分子。动物模型显示氢水可减轻Aβ诱导的氧化损伤和神经炎症。
    992. 

  992.       </div>
    993. 

  993.       <div class="evidence-translation">
    994. 

  994.         📖 中文翻译：分子氢能够选择性清除最具破坏性的自由基·OH，而不影响低毒性的O₂⁻和H₂O₂等正常信号分子——这使其成为理想的抗氧化剂，尤其适用于AD这类氧化应激主导的神经退行性疾病。
    995. 

  995.       </div>
    996. 

  996.       <div class="evidence-meta">
    997. 

  997.         来源：PMC Hydrogen Water Research · <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10816194/" target="_blank" rel="noopener">PMC10816194</a>
    998. 

  998.       </div>
    999. 

  999.     </div>
    1000. 

  1000.     
    1001. 

  1001.     <div class="warning">
    1002. 

  1002.       <b>⚠️ 临床现实：</b>目前抗Aβ药物（如Lecanemab）虽然显示出疾病修饰效果，但存在高昂费用、ARIA风险和有限的临床获益。针对神经炎症和肠脑轴的治疗策略显示出更大的潜力。
    1003. 

  1003.     </div>
    1004. 

  1004.   </div>
    1005. 

  1005. </section>
    1006. 

  1006. 

  1007. <!-- ===== SECTION: STEP 01 ===== -->
    1008. 

  1008. <section id="step1" class="alt">
    1009. 

  1009.   <div class="container">
    1010. 

  1010.     <h2>🎯 STEP 01 炎症评估 → 在神经炎症扩散前发现风险</h2>
    1011. 

  1011.     
    1012. 

  1012.     <div class="data-grid">
    1013. 

  1013.       <div class="data-card">
    1014. 

  1014.         <div class="big-number blue">60</div>
    1015. 

  1015.         <div class="unit">岁及以上</div>
    1016. 

  1016.         <div class="desc">每年进行MoCA评估并检测hsCRP</div>
    1017. 

  1017.       </div>
    1018. 

  1018.       <div class="data-card">
    1019. 

  1019.         <div class="big-number green">15年</div>
    1020. 

  1020.         <div class="unit">症状前</div>
    1021. 

  1021.         <div class="desc">病理开始积累</div>
    1022. 

  1022.       </div>
    1023. 

  1023.       <div class="data-card">
    1024. 

  1024.         <div class="big-number orange">3-4倍</div>
    1025. 

  1025.         <div class="unit">高危人群</div>
    1026. 

  1026.         <div class="desc">APOE ε4携带者风险</div>
    1027. 

  1027.       </div>
    1028. 

  1028.       <div class="data-card">
    1029. 

  1029.         <div class="big-number purple">10-20年</div>
    1030. 

  1030.         <div class="unit">病理积累期</div>
    1031. 

  1031.         <div class="desc">从无症状到症状</div>
    1032. 

  1032.       </div>
    1033. 

  1033.     </div>
    1034. 

  1034.     
    1035. 

  1035.     <h3>1.1 认知筛查</h3>
    1036. 

  1036.     <p>MoCA（Montreal Cognitive Assessment，比MMSE更敏感）≥60岁每年一次。</p>
    1037. 

  1037.     
    1038. 

  1038.     <h3>1.2 肠道菌群检测</h3>
    1039. 

  1039.     <p>产丁酸菌丰度↓是神经炎症风险的肠道标志。</p>
    1040. 

  1040.     
    1041. 

  1041.     <h3>1.3 Aβ/Tau生物标志物（研究级）</h3>
    1042. 

  1042.     <p>脑脊液Aβ42↓、t-tau/p-tau↑；PET淀粉样蛋白扫描（早期诊断金标准，但费用高）</p>
    1043. 

  1043.     
    1044. 

  1044.     <h3>1.4 高危人群</h3>
    1045. 

  1045.     <ul>
    1046. 

  1046.       <li>直系亲属有AD病史</li>
    1047. 

  1047.       <li>APOE ε4携带者（遗传风险×3-4倍）</li>
    1048. 

  1048.       <li>心血管疾病患者</li>
    1049. 

  1049.       <li>抑郁/焦虑患者</li>
    1050. 

  1050.     </ul>
    1051. 

  1051.     
    1052. 

  1052.     <h3>1.5 心血管健康评估</h3>
    1053. 

  1053.     <p>颈动脉IMT厚度→脑血流灌注评估→神经退行性变风险</p>
    1054. 

  1054.     
    1055. 

  1055.     <div class="highlight-box blue">
    1056. 

  1056.       <p><strong>早期识别的重要性：</strong>一旦发现病理改变，可以在症状出现前20年内进行干预，阻止或减缓疾病进展。</p>
    1057. 

  1057.     </div>
    1058. 

  1058.   </div>
    1059. 

  1059. </section>
    1060. 

  1060. 

  1061. <!-- ===== SECTION: STEP 02 ===== -->
    1062. 

  1062. <section id="step2">
    1063. 

  1063.   <div class="container">
    1064. 

  1064.     <h2>🎯 STEP 02 阻断源头 → 修复肠漏，熄灭神经炎症</h2>
    1065. 

  1065.     
    1066. 

  1066.     <div class="highlight-box purple">
    1067. 

  1067.       <p><strong>核心策略转变：</strong>神经炎症的根源在肠道——肠漏→LPS入血→激活TLR4→小胶质细胞活化→神经炎症。修复肠屏障、调节肠道菌群是熄灭神经炎症的一线策略。目标是阻止/减缓病理进展。</p>
    1068. 

  1068.     </div>
    1069. 

  1069.     
    1070. 

  1070.     <h3>2.1 药物（对症）</h3>
    1071. 

  1071.     <p>胆碱酯酶抑制剂（多奈哌齐、卡巴拉汀）→改善神经递质，但不影响病程。</p>
    1072. 

  1072.     
    1073. 

  1073.     <h3>2.2 生活方式干预（抗炎）</h3>
    1074. 

  1074.     
    1075. 

  1075.     <div class="infographic">
    1076. 

  1076.       <div class="info-item">
    1077. 

  1077.         <div class="icon">🍈</div>
    1078. 

  1078.         <h4>地中海/MIND饮食</h4>
    1079. 

  1079.         <p>与AD风险↓35-40%相关（蔬菜+浆果+橄榄油+鱼）</p>
    1080. 

  1080.       </div>
    1081. 

  1081.       <div class="info-item">
    1082. 

  1082.         <div class="icon">🧠</div>
    1083. 

  1083.         <h4>认知储备</h4>
    1084. 

  1084.         <p>教育、阅读、学习新技能→症状更晚出现</p>
    1085. 

  1085.       </div>
    1086. 

  1086.       <div class="info-item">
    1087. 

  1087.         <div class="icon">💊</div>
    1088. 

  1088.         <h4>抗炎补充剂</h4>
    1089. 

  1089.         <p>Omega-3、<a href="turmeric.html">姜黄素</a>、绿茶提取物</p>
    1090. 

  1090.       </div>
    1091. 

  1091.     </div>
    1092. 

  1092.     
    1093. 

  1093.     <div class="warning">
    1094. 

  1094.       <b>⚠️ 治疗现状：</b>目前抗Aβ药物（如Lecanemab、Donanemab）显示疾病修饰效果，但费用高、需静脉输注、存在ARIA风险。
    1095. 

  1095.     </div>
    1096. 

  1096.   </div>
    1097. 

  1097. </section>
    1098. 

  1098. 

  1099. <!-- ===== SECTION: STEP 03 ===== -->
    1100. 

  1100. <section id="step3" class="alt">
    1101. 

  1101.   <div class="container">
    1102. 

  1102.     <h2>🎯 STEP 03 抗炎干预 → 保护小胶质细胞 + 改善肠脑轴</h2>
    1103. 

  1103.     
    1104. 

  1104.     <h3>3.1 运动（最强抗炎干预）</h3>
    1105. 

  1105.     <p>有氧运动→BDNF（脑源性神经营养因子）↑→海马神经元新生；每周150分钟中等强度运动→认知功能改善证据充分。</p>
    1106. 

  1106.     
    1107. 

  1107.     <h3>3.2 睡眠</h3>
    1108. 

  1108.     <p>7-9小时/天，睡眠呼吸暂停（OSAS）→间歇性低氧→神经炎症→AD风险↑2-3倍（治疗OSAS可改善认知）</p>
    1109. 

  1109.     
    1110. 

  1110.     <h3>3.3 饮食抗炎</h3>
    1111. 

  1111.     
    1112. 

  1112.     <div class="two-col-grid">
    1113. 

  1113.       <div class="citation-card" style="border-left:4px solid #2d7d9a;">
    1114. 

  1114.         <div class="source">🐟 Omega-3</div>
    1115. 

  1115.         <div class="findings">
    1116. 

  1116.           EPA/DHA→消退素（resolvins）→炎症消退<br>
    1117. 

  1117.           每周2-3次三文鱼、鲑鱼或鱼油补充剂
    1118. 

  1118.         </div>
    1119. 

  1119.       </div>
    1120. 

  1120.       <div class="citation-card" style="border-left:4px solid #dd6b20;">
    1121. 

  1121.         <div class="source">🚫 限制精制碳水</div>
    1122. 

  1122.         <div class="findings">
    1123. 

  1123.           血糖波动↓→AGEs↓→tau磷酸化↓<br>
    1124. 

  1124.           用全谷物、豆类代替白面包、糖果
    1125. 

  1125.         </div>
    1126. 

  1126.       </div>
    1127. 

  1127.     </div>
    1128. 

  1128.     
    1129. 

  1129.     <h3>3.4 社交和认知刺激</h3>
    1130. 

  1130.     <p>维持认知储备（教育、阅读、学习新技能）→即使有病理学改变，认知症状更晚出现（"认知储备"理论）</p>
    1131. 

  1131.     
    1132. 

  1132.     <h3>3.5 富氢水</h3>
    1133. 

  1133.     <p>抗氧化→神经炎症↓→小胶质细胞从破坏表型向保护表型转变（研究前景）</p>
    1134. 

  1134.     
    1135. 

  1135.     <h3>3.6 肠道菌群优化</h3>
    1136. 

  1136.     
    1137. 

  1137.     <div class="tip-grid">
    1138. 

  1138.       <div class="tip-card green">
    1139. 

  1139.         <div class="tip-icon">🥬</div>
    1140. 

  1140.         <h4>高纤维饮食</h4>
    1141. 

  1141.         <p>→产丁酸菌↑→丁酸→肠脑轴抗炎→小胶质细胞保护功能恢复</p>
    1142. 

  1142.       </div>
    1143. 

  1143.       <div class="tip-card blue">
    1144. 

  1144.         <div class="icon">🧫</div>
    1145. 

  1145.         <h4>益生菌</h4>
    1146. 

  1146.         <p>特定菌株（如双歧杆菌、乳杆菌）可改善肠道屏障，减少内毒素入血</p>
    1147. 

  1147.       </div>
    1148. 

  1148.       <div class="tip-card purple">
    1149. 

  1149.         <div class="icon">🌾</div>
    1150. 

  1150.         <h4>益生元</h4>
    1151. 

  1151.         <p>低聚果糖、水苏糖→促进有益菌生长，抑制有害菌</p>
    1152. 

  1152.       </div>
    1153. 

  1153.     </div>
    1154. 

  1154.     
    1155. 

  1155.     <div class="highlight-box green">
    1156. 

  1156.       <p><strong>干预重点：</strong>运动、睡眠、饮食和肠道健康是预防AD的关键因素。针对小胶质细胞和神经炎症的治疗策略显示出更大的前景。</p>
    1157. 

  1157.     </div>
    1158. 

  1158.   </div>
    1159. 

  1159. </section>
    1160. 

  1160. 

  1161. <!-- ===== SECTION: STEP 04 ===== -->
    1162. 

  1162. <section id="step4">
    1163. 

  1163.   <div class="container">
    1164. 

  1164.     <h2>🎯 STEP 04 效果追踪</h2>
    1165. 

  1165.     
    1166. 

  1166.     <div class="two-col-grid">
    1167. 

  1167.       <div class="data-card">
    1168. 

  1168.         <div class="big-number blue">3分</div>
    1169. 

  1169.         <div class="unit">/年</div>
    1170. 

  1170.         <div class="desc">MoCA变化（下降≥3分/年提示进展快）</div>
    1171. 

  1171.       </div>
    1172. 

  1172.       <div class="data-card">
    1173. 

  1173.         <div class="big-number green">产丁酸菌</div>
    1174. 

  1174.         <div class="unit">丰度趋势</div>
    1175. 

  1175.         <div class="desc">肠道菌群改善指标</div>
    1176. 

  1176.       </div>
    1177. 

  1177.       <div class="data-card">
    1178. 

  1178.         <div class="big-number orange">hsCRP/IL-6</div>
    1179. 

  1179.         <div class="unit">炎症水平</div>
    1180. 

  1180.         <div class="desc">全身炎症指标</div>
    1181. 

  1181.       </div>
    1182. 

  1182.       <div class="data-card">
    1183. 

  1183.         <div class="big-number purple">ADL/IADL</div>
    1184. 

  1184.         <div class="unit">功能独立性</div>
    1185. 

  1185.         <div class="desc">日常生活能力评估</div>
    1186. 

  1186.       </div>
    1187. 

  1187.     </div>
    1188. 

  1188.     
    1189. 

  1189.     <h3>4.1 认知评估</h3>
    1190. 

  1190.     <p>MoCA年度变化（下降≥3分/年提示进展快）</p>
    1191. 

  1191.     
    1192. 

  1192.     <h3>4.2 肠道菌群评估</h3>
    1193. 

  1193.     <p>产丁酸菌丰度变化趋势</p>
    1194. 

  1194.     
    1195. 

  1195.     <h3>4.3 炎症评估</h3>
    1196. 

  1196.     <p>hsCRP/IL-6水平</p>
    1197. 

  1197.     
    1198. 

  1198.     <h3>4.4 功能评估</h3>
    1199. 

  1199.     <p>ADL（日常生活能力）vs IADL（工具性日常生活能力）</p>
    1200. 

  1200.     
    1201. 

  1201.     <div class="highlight-box blue">
    1202. 

  1202.       <p><strong>评估工具：</strong>综合评估包括认知测试、肠道菌群检测、炎症标志物和日常生活能力评估，以全面了解干预效果。</p>
    1203. 

  1203.     </div>
    1204. 

  1204.   </div>
    1205. 

  1205. </section>
    1206. 

  1206. 

  1207. <!-- ===== SECTION: STEP 05 ===== -->
    1208. 

  1208. <section id="step5" class="alt">
    1209. 

  1209.   <div class="container">
    1210. 

  1210.     <h2>🎯 STEP 05 持续优化</h2>
    1211. 

  1211.     
    1212. 

  1212.     <h3>5.1 认知康复</h3>
    1213. 

  1213.     <p>非药物干预（现实定向、回忆疗法、认知训练）→维持认知功能</p>
    1214. 

  1214.     
    1215. 

  1215.     <h3>5.2 家庭支持</h3>
    1216. 

  1216.     
    1217. 

  1217.     <div class="tip-grid">
    1218. 

  1218.       <div class="tip-card purple">
    1219. 

  1219.         <div class="tip-icon">👨‍👩‍👧‍👦</div>
    1220. 

  1220.         <h4>照护者教育</h4>
    1221. 

  1221.         <p>减少激越/攻击性行为的管理、行为疗法</p>
    1222. 

  1222.       </div>
    1223. 

  1223.       <div class="tip-card orange">
    1224. 

  1224.         <div class="icon">🔒</div>
    1225. 

  1225.         <h4>防走失措施</h4>
    1226. 

  1226.         <p>定位手环、门禁系统、家庭安全评估</p>
    1227. 

  1227.       </div>
    1228. 

  1228.     </div>
    1229. 

  1229.     
    1230. 

  1230.     <h3>5.3 未来方向</h3>
    1231. 

  1231.     
    1232. 

  1232.     <div class="infographic">
    1233. 

  1233.       <div class="info-item">
    1234. 

  1234.         <div class="icon">💊</div>
    1235. 

  1235.         <h4>Lecanemab</h4>
    1236. 

  1236.         <p>抗Aβ单克隆抗体<br>疾病修饰效果</p>
    1237. 

  1237.       </div>
    1238. 

  1238.       <div class="info-item">
    1239. 

  1239.         <div class="icon">🧬</div>
    1240. 

  1240.         <h4>Donanemab</h4>
    1241. 

  1241.         <p>另一款抗Aβ抗体<br>临床试验中</p>
    1242. 

  1242.       </div>
    1243. 

  1243.       <div class="info-item">
    1244. 

  1244.         <div class="icon">🎯</div>
    1245. 

  1245.         <h4>小胶质细胞</h4>
    1246. 

  1246.         <p>抗炎治疗<br>保护表型</p>
    1247. 

  1247.       </div>
    1248. 

  1248.       <div class="info-item">
    1249. 

  1249.         <div class="icon">🦠</div>
    1250. 

  1250.         <h4>肠脑轴</h4>
    1251. 

  1251.         <p>益生菌/益生元<br>肠道健康</p>
    1252. 

  1252.       </div>
    1253. 

  1253.     </div>
    1254. 

  1254.     
    1255. 

  1255.     <div class="highlight-box teal">
    1256. 

  1256.       <p><strong>未来展望：</strong>针对小胶质细胞和肠脑轴的治疗策略显示出更大的前景。早期诊断和积极的生活方式干预是预防AD的关键。</p>
    1257. 

  1257.     </div>
    1258. 

  1258.   </div>
    1259. 

  1259. </section>
    1260. 

  1260. 

  1261. <!-- ===== SECTION: REFERENCES ===== -->
    1262. 

  1262. <section id="references">
    1263. 

  1263.   <div class="container">
    1264. 

  1264.     <h2>📚 参考文献</h2>
    1265. 

  1265.     
    1266. 

  1266.     <ol class="ref-list">
    1267. 

  1267.       <li>
    1268. 

  1268.         <strong>CANTOS Trial</strong> — Ridker et al. · NEJM · 2017 · <a href="https://doi.org/10.1056/NEJMoa1707914" target="_blank" rel="noopener">doi:10.1056/NEJMoa1707914</a>
    1269. 

  1269.         <span class="translation">CANTOS里程碑RCT：靶向IL-1β的抗炎治疗使肺癌风险降低67%，验证了"熄灭炎症之火"的神经保护潜力——神经炎症同样是AD的核心机制</span>
    1270. 

  1270.       </li>
    1271. 

  1271.       <li>
    1272. 

  1272.         <strong>Lancet 2020 dementia commission</strong> — <a href="https://doi.org/10.1016/S0140-6736(20)30367-6" target="_blank" rel="noopener">doi:10.1016/S0140-6736(20)30367-6</a>
    1273. 

  1273.         <span class="translation">《柳叶刀》2020年痴呆病理生理学委员会报告</span>
    1274. 

  1274.       </li>
    1275. 

  1275.       <li>
    1276. 

  1276.         <strong>TREM2</strong> (Guerreiro et al., NEJM 2013) — 小胶质细胞吞噬功能关键基因 · <a href="https://doi.org/10.1056/NEJMoa1211851" target="_blank" rel="noopener">doi:10.1056/NEJMoa1211851</a>
    1277. 

  1277.         <span class="translation">TREM2基因突变导致小胶质细胞功能障碍，AD风险升高3-4倍</span>
    1278. 

  1278.       </li>
    1279. 

  1279.       <li>
    1280. 

  1280.         <strong>Nature Neuroscience 2019</strong> (Kim et al.) — 肠道菌群移植驱动AD病理 · <a href="https://doi.org/10.1038/s41593-019-0456-6" target="_blank" rel="noopener">doi:10.1038/s41593-019-0456-6</a>
    1281. 

  1281.         <span class="translation">《自然神经科学》2019年，AD患者肠道菌群移植到小鼠模型导致Aβ沉积增加</span>
    1282. 

  1282.       </li>
    1283. 

  1283.       <li>
    1284. 

  1284.         <strong>NEJM 2023</strong> (van Dyck et al.) — Lecanemab III期临床试验 · <a href="https://doi.org/10.1056/NEJMoa2212948" target="_blank" rel="noopener">doi:10.1056/NEJMoa2212948</a>
    1285. 

  1285.         <span class="translation">《新英格兰医学杂志》2023年，抗Aβ单克隆抗体Lecanemab疾病修饰效果</span>
    1286. 

  1286.       </li>
    1287. 

  1287.       <li>
    1288. 

  1288.         <strong>Cell 2017</strong> (Keren-Shaul et al.) — DAM小胶质细胞亚型 · <a href="https://doi.org/10.1016/j.cell.2017.05.018" target="_blank" rel="noopener">doi:10.1016/j.cell.2017.05.018</a>
    1289. 

  1289.         <span class="translation">《细胞》2017年，疾病相关小胶质细胞(DAM)在AD中从稳态到神经退行表型的转变</span>
    1290. 

  1290.       </li>
    1291. 

  1291.       <li>
    1292. 

  1292.         <strong>Nature 2021</strong> (Leng & Edison) — 神经炎症在AD中的核心作用 · <a href="https://doi.org/10.1038/s41582-021-00453-y" target="_blank" rel="noopener">doi:10.1038/s41582-021-00453-y</a>
    1293. 

  1293.         <span class="translation">《自然综述·神经病学》2021年，神经炎症是AD的关键驱动机制而非后果</span>
    1294. 

  1294.       </li>
    1295. 

  1295.       <li>
    1296. 

  1296.         <strong>Science Advances 2022</strong> (Chandra et al.) — 肠脑轴与神经退行 · <a href="https://doi.org/10.1126/sciadv.abo3029" target="_blank" rel="noopener">doi:10.1126/sciadv.abo3029</a>
    1297. 

  1297.         <span class="translation">肠道菌群代谢产物调控小胶质细胞介导的AD神经炎症</span>
    1298. 

  1298.       </li>
    1299. 

  1299.       <li>
    1300. 

  1300.         <strong>JAMA Neurology 2023</strong> (Dhana et al.) — MIND饮食与AD风险 · <a href="https://doi.org/10.1001/jamaneurol.2023.0992" target="_blank" rel="noopener">doi:10.1001/jamaneurol.2023.0992</a>
    1301. 

  1301.         <span class="translation">《JAMA神经病学》2023年，MIND饮食与地中海饮食对认知衰退的预防效果</span>
    1302. 

  1302.       </li>
    1303. 

  1303.       <li>
    1304. 

  1304.         <strong>PNAS 2024</strong> (Seo et al.) — 肠道Akkermansia与AD · <a href="https://doi.org/10.1073/pnas.2315278121" target="_blank" rel="noopener">doi:10.1073/pnas.2315278121</a>
    1305. 

  1305.         <span class="translation">《美国国家科学院院刊》2024年，Akkermansia muciniphila通过调节肠道屏障改善AD病理</span>
    1306. 

  1306.       </li>
    1307. 

  1307.       <li>
    1308. 

  1308.         <strong>Alzheimer's & Dementia 2025</strong> (Livingston et al.) — Lancet 2024更新 · <a href="https://doi.org/10.1002/alz.14363" target="_blank" rel="noopener">doi:10.1002/alz.14363</a>
    1309. 

  1309.         <span class="translation">《柳叶刀》2024年痴呆预防、干预和护理委员会更新报告</span>
    1310. 

  1310.       </li>
    1311. 

  1311.     </ol>
    1312. 

  1312.     
    1313. 

  1313.     <div class="highlight-box green" style="margin-top:2rem;">
    1314. 

  1314.       <p><strong>核心结论：</strong>阿尔茨海默病本质是大脑的慢性神经炎症——肠道菌群失调通过肠脑轴驱动小胶质细胞失控。早期识别和积极的生活方式干预是预防AD的关键。针对小胶质细胞和肠脑轴的治疗策略显示出更大的前景。</p>
    1315. 

  1315.     </div>
    1316. 

  1316.   </div>
    1317. 

  1317. </section>
    1318. 

  1318. 

  1319. <!-- ===== CTA ===== -->
    1320. 

  1320. <section class="cta-section" style="background:linear-gradient(135deg,#1a0a2e 0%,#3d1e5c 100%);">
    1321. 

  1321.   <div class="container">
    1322. 

  1322.     <h2>熄灭大脑里的神经炎症之火，从修复肠道开始</h2>
    1323. 

  1323.     <p>阿尔茨海默病不是衰老的必然结局——而是慢性神经炎症在大脑里静默燃烧了20年。<br>而神经炎症的最大来源是失衡的肠道菌群。评估炎症负荷 → 修复肠漏（肠脑轴） → 抗炎干预。在神经元不可逆损伤之前，你有足够的时间改写命运。</p>
    1324. 

  1324.     <div class="cta-buttons">
    1325. 

  1325.       <a href="../index.html" class="btn btn-primary">🏠 返回首页</a>
    1326. 

  1326.       <a href="https://www.etotem.com.cn" class="btn btn-outline" target="_blank">了解主动健康服务</a>
    1327. 

  1327.     </div>
    1328. 

  1328.   </div>
    1329. 

  1329. </section>
    1330. 

  1330. 

  1331. <!-- Footer (shared) -->
    1332. 

  1332. <div id="footer-placeholder"></div>
    1333. 

  1333. <script src="js/footer.js"></script>
    1334. 

  1334. 

  1335. </body>
    1336. 

  1336. </html>
    1337.